1INTRODUCTIONThe natural history of early cervical adenocarcinoma is not fully understood, and proper disease management is controversial. In Japan, stage IA cervical adenocarcinoma is defined as microinvasive adenocarcinoma confined to the region of the normal endocervical glands; subclassification was not incorporated in the Japanese general rules for clinical and pathological management until March 2012. For this reason, the Japanese definition differs from that specified by the International Federation of Gynecology and Obstetrics (FIGO) in 2008, in which states that stage IA refers to a lesion with a depth of invasion depth of 5 mm or less.Depth of invasion is among the criteria used to predict pelvic lymph‐node metastasis and disease recurrence. In this study, we evaluated the validity of our operative procedures and prognostic outcomes in order to standardize surgical procedures for FIGO stage IA1 cervical adenocarcinoma.2PATIENTS AND METHODSA total of 120 patients with adenocarcinoma of the uterine cervix were treated at the Department of Gynecology and Obstetrics of Kyushu University Hospital between 2005 and 2011. Twelve of the 120 patients were treated for microinvasive adenocarcinoma, defined according to the FIGO classification system as stage IA1; all medical records were retrospectively reviewed for these 12 patients. We obtained written
Asia-Pacific Journal of Clinical Oncology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera